DNV3837 antibiotic candidate: the Phase II trial continues in the US
15 juil. 2020 12h30 HE
|
Deinove
DNV3837 antibiotic candidate: the Phase II trial continues in the United States, despite a disrupted context due to the COVID-19 outbreak DEINOVE (Euronext Growth Paris: ALDEI), a French biotech...